We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Primary Rituximab and Maintenance

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00140582
First Posted: September 1, 2005
Last Update Posted: March 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
HOVON - Dutch Haemato-Oncology Association
German Low Grade Lymphoma Study Group (GLSG/OSHO)
Australasian Leukaemia and Lymphoma Group
Institute of Cancer Research, United Kingdom
Information provided by (Responsible Party):
Lymphoma Study Association
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2016
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):